View Older Stories View More Recent Stories
-
These stocks are new additions to Mizuho's 'Americas Top Picks' list
-
UBS Reiterates Buy Rating on CVS Health (CVS) as Stock 'Well-Liked by Investors'
-
CVS Health names David Joyner chair of board effective January 1
-
Aetna launches AI assistant for healthcare navigation
-
CVS Health (CVS) call put ratio 4.6 calls to 1 put with a focus on November 80, 82 and 85 calls
-
CVS Health (CVS) PT Raised to $95 at Evercore ISI
-
CVS raises earnings forecast despite flagging $5.7 billion impariment charge
-
CVS Health (CVS) Tops Q3 EPS by 23c, Beats on Revenue; Offers FY25 EPS Guidance
-
CVS Health earnings preview Q3: strong print expected, turnaround in focus
-
CVS Health (CVS) call put ratio 1.1 calls to 1 put into quarter results
-
Cantor Fitzgerald Reiterates Overweight on CVS Health, Cites Strong Star Ratings
-
Cantor Fitzgerald Reiterates Neutral on Molina Healthcare (MOH), Highlights 2026 Stars Progress
-
Mizuho Positive on CVS Health (CVS): 'We believe this is a positive for CVS'
-
BofA adds 4 stocks to its Global Contenders list
-
Cantor Fitzgerald Reiterates Neutral Rating on Molina Healthcare (MOH)
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Trump: Working On Lowering Cost Of Health Insurance
-
Piper Sandler: 'We Are Incrementally Positive on CVS, ALHC and UNH'
-
CVS Health (CVS) Says Some Pharmacies Impacted By Tech Glitches - Bloomberg
-
CVS Health subsidiary Omnicare files for Chapter 11 bankruptcy
-
Aetna to expand clinical collaboration program to ten hospitals by 2025
-
CVS Health (CVS) PT Raised to $85 at Wolfe Research
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 3.6% Yield
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Gilead stock falls after CVS holds off adding HIV prevention shot to plans
-
BMO Capital on Gilead Sciences (GILD): 'Expect GILD shares to be weaker on this announcement'
-
CVS Health (CVS) not yet adding Gilead's Yeztugo to its commercial or ACA plans - Reuters
-
Jefferies Reiterates Buy Rating on CVS Health (CVS)
-
UBS Upgrades CVS Health (CVS) to Buy
-
Baird Upgrades CVS Health (CVS) to Outperform
-
UnitedHealth Group (UNH), Humana (HUM), Others Climb
-
Truist: 'We Remain Bullish on CVS Health (CVS)'
-
CVS Health (CVS) Tops Q2 EPS by 35c, Beats on Revenue; Offers FY25 EPS Guidance
-
Analysts see stable EPS outlook for CVS ahead of Q2 results despite utilization headwinds
-
CVS Health (CVS) call put ratio 2 calls to 1 put into the expected release of quarter results
-
CVS Health (CVS) PT Lowered to $67 at UBS
-
15 names that Morgan Stanley’s analysts expect to move meaningfully on earnings
-
Humana stock falls after losing Medicare bonus payment lawsuit
-
Humana (HUM) Loses Medicare Bonus Payment Lawsuit - Bloomberg
-
CVS Health (CVS) Declares $0.665 Quarterly Dividend; 3.9% Yield
-
TD Cowen on CVS Health (CVS): 'CNC's Pain Could Be CVS's Gain'
-
CVS Health (CVS) call put ratio 1.4 calls to 1 put
-
CVS Health (CVS) opens new WITC in Chicago
-
Cantor Fitzgerald Upgrades CVS Health (CVS) to Overweight
-
Medicare Pharmacy Benefit Manager Limits Stripped From Tax Bill - Bloomberg
-
Medicare Surfaces as Target for Cuts to Pay for Trump Tax Bill'- Bloomberg
-
Mizuho updates U.S. top picks: Adds CVS Health, PayPal and Oracle
-
Cantor Fitzgerald Reiterates Overweight Rating on CVS Health (CVS)
-
Cantor Fitzgerald says CMS' new audit strategy has logistical challenges
-
Keybanc: 'CMS Expanding RADV Audits, MA Can't Catch a Break'
